These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16515775)

  • 1. ACE inhibitors and statins for bone marrow failure following myocardial infarction?
    Post MJ; Waltenberger J
    Cardiovasc Res; 2006 Apr; 70(1):1-2. PubMed ID: 16515775
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cells.
    Thum T; Fraccarollo D; Galuppo P; Tsikas D; Frantz S; Ertl G; Bauersachs J
    Cardiovasc Res; 2006 Apr; 70(1):50-60. PubMed ID: 16480696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function: simply effects of optimized drug treatment?
    Thum T; Bauersachs J
    Eur Heart J; 2005 Aug; 26(16):1685; author reply 1685-6. PubMed ID: 15958435
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease.
    Mancini GB; Etminan M; Zhang B; Levesque LE; FitzGerald JM; Brophy JM
    J Am Coll Cardiol; 2006 Jun; 47(12):2554-60. PubMed ID: 16781387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
    Austin PC; Tu JV; Ko DT; Alter DA
    CMAJ; 2008 Oct; 179(9):901-8. PubMed ID: 18936455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis.
    Choudhry NK; Avorn J; Antman EM; Schneeweiss S; Shrank WH
    Health Aff (Millwood); 2007; 26(1):186-94. PubMed ID: 17211028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of other drugs apart from antithrombotic and antiplatelet agents for the treatment of non-ST-elevation acute coronary syndromes].
    Birdane A; Ata N
    Anadolu Kardiyol Derg; 2006 Apr; 6 Suppl 1():30-4. PubMed ID: 16613773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of statin treatment after myocardial infarction: Is progenitor cell mobilization the missing link?
    Tousoulis D; Kaski JC; Antoniades C; Stefanadis C
    Int J Cardiol; 2008 Nov; 130(3):301-3. PubMed ID: 18715656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of ACE-inhibitors following myocardial infarction].
    Luomanmäki K
    Duodecim; 1993; 109(5):349-52. PubMed ID: 8020397
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential novel pharmacological therapies for myocardial remodelling.
    Landmesser U; Wollert KC; Drexler H
    Cardiovasc Res; 2009 Feb; 81(3):519-27. PubMed ID: 19019834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts.
    Yang YJ; Qian HY; Huang J; Li JJ; Gao RL; Dou KF; Yang GS; Willerson JT; Geng YJ
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2076-82. PubMed ID: 19762786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins and the endothelium.
    Ii M; Losordo DW
    Vascul Pharmacol; 2007 Jan; 46(1):1-9. PubMed ID: 16920035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical management after myocardial infarction.
    Aronow WS
    Future Cardiol; 2019 May; 15(3):135-138. PubMed ID: 31148480
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials.
    Tokmakova M; Solomon SD
    Curr Opin Cardiol; 2006 Jul; 21(4):268-72. PubMed ID: 16755193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
    Richter B; Derntl M; Marx M; Lercher P; Gössinger HD
    Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
    Filippi A; D'Ambrosio G; Giustini SE; Pecchioli S; Mazzaglia G; Cricelli C
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tako-tsubo syndrome associated with sexual intercourse.
    Tomcsányi J; Marosi A; Arabadzisz K; Zsoldos A; Bózsik B
    Int J Cardiol; 2007 Oct; 121(3):e28-9. PubMed ID: 17884207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Afibrinogenaemia: a rare cause of young myocardial infarct.
    Kumar N; Padma Kumar R; Ramesh B; Garg N
    Singapore Med J; 2008 Apr; 49(4):e104-6. PubMed ID: 18418510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age.
    Setoguchi S; Glynn RJ; Avorn J; Levin R; Winkelmayer WC
    Am J Cardiol; 2007 Oct; 100(7):1061-7. PubMed ID: 17884362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?
    Hudson M; Richard H; Pilote L
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):773-85. PubMed ID: 17486661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.